Tissue distribution of the opioid receptor-like (ORL1) receptor
about
Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOPFunctional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonistsPeptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agentsPharmacological properties of nociceptin/orphanin FQ-induced stimulation and inhibition of cyclic AMP formation in distinct layers of rat olfactory bulbOpioid receptor-like 1 stimulation in the collecting duct induces aquaresis through vasopressin-independent aquaporin-2 downregulationEffects of nociceptin/orphanin FQ on rats with cathartic colonDysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.Nociceptin/orphanin FQ: actions within the brain.Structural requirements of N-substituted spiropiperidine analogues as agonists of nociceptin/orphanin FQ receptorNOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics.Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.Central N/OFQ-NOP Receptor System in Pain Modulation.Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system.Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians.Development of nociceptin receptor (NOP) agonists and antagonists.UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.Opioid system and Alzheimer's disease.Buprenorphine for cancer pain: is it ready for prime time?Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence.Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitariusRandom Forest Segregation of Drug Responses May Define Regions of Biological Significance.Diabetes-induced changes in the morphology and nociceptinergic innervation of the rat uterus.Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.Synthesis, biological evaluation and structural characterization of novel glycopeptide analogues of nociceptin N/OFQ.Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel.Bradycardia elicited by microinjections of nociceptin/orphanin FQ into the intermediolateral cell column at T1-T2 in the rat.Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.Role of nitric oxide in mediating vasodilator responses to opioid peptides in the rat.Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.Glycinergic inputs to cardiac vagal neurons in the nucleus ambiguus are inhibited by nociceptin and mu-selective opioids.Mechanism of cardiovascular effects of nociceptin microinjected into the nucleus tractus solitarius of the rat.Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
P2860
Q24647921-20610FC6-ED3C-4234-95EB-FA528AD42EB8Q26852027-D463BE02-A6D2-417C-B67B-F9FF32AA2B9BQ28178485-12850ACA-5AAD-45D0-803B-354FFDFFE937Q28344895-740BBC46-20F4-4B1B-B8BC-B6D436B15C8CQ28569227-CB1DF19B-6339-4006-B6E5-F0184D48E4B8Q33787537-3B86CD05-6218-432F-9997-16D5D786E6EEQ34764672-EE9AE224-8553-453E-94C3-487DE40343A8Q35112207-19967312-5A63-470D-8ABF-1D8F0B453854Q35669512-10A38604-A125-4076-A480-A7706E350DE7Q35708377-79CECB7F-B022-4ACC-90FA-9D7A87B44DBCQ35968136-8F97C45D-9A97-4F97-BA4C-086D3EBA1923Q36081575-3B75F3FA-8BED-47D2-8C4A-433908997F9CQ36776707-83F84AF1-0AA5-4236-AFEF-4672DA635858Q37094760-05E592B4-DF67-476E-B124-8085C53708E1Q37100461-55070FFC-1354-4C0D-84CC-E3B4771E1DD7Q37320271-CCEE72D0-66A6-434C-8F95-6DBF0D9A29B6Q37680813-42A382BB-962A-450E-99D6-966F77B203B9Q37760247-971DCB5B-EEF3-4561-8547-DE92FA36A961Q38004941-7C817B12-E057-4AC3-AB8E-528FAB843BBDQ38243938-A7D86947-E8AF-4311-8779-431CA1D5D512Q38344663-8B8BC18B-B107-4176-99B5-2F0E81BAA733Q38477907-BB9AA9EF-B271-4CAA-8AF2-CED23516C22BQ38756895-66A8B804-569B-4C16-A484-93E326E58A53Q38852152-7AD9816B-4881-4EF1-BACE-5AC28D562693Q38940617-790F82D9-B52B-46C1-85A6-CAB209AAF094Q39296074-27A9AB86-D64B-49BE-A05B-12E97FF4D925Q39503988-C75BDFE5-52CC-44E7-B801-0B22ACDC295EQ41493064-39DAF8F0-5B43-443C-97B9-8A356F1B6217Q41860629-FF66ABC8-21D5-48F0-8C0F-9E2142727ABFQ41876384-B31164FC-42C2-4E4C-B6E2-4329EE529E44Q41953872-9B906828-F6A2-4E7A-805F-D2A2223CF04FQ42699951-E97E5C51-95A6-4713-9EC9-A20FEF2108E0Q42861371-EA114192-4895-4CA3-93DC-698719BE053CQ42905505-039E730D-326E-493F-B1D9-3129599F448BQ43165858-6185445D-BE5E-450B-8B43-C78B93087242Q43925207-46A81407-B580-4DA7-BB19-204ED6EB33EEQ44342818-5D30E868-94F4-4D6E-A3FA-4CD4940007C4Q44449856-F164DDE3-4358-483E-A91E-81E8F8062E14Q45232045-A15226E3-2308-4AD9-8EFF-329E9865FBB0Q46841584-CA60B40D-B28C-4561-B711-32614D08E27E
P2860
Tissue distribution of the opioid receptor-like (ORL1) receptor
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tissue distribution of the opioid receptor-like (ORL1) receptor
@ast
Tissue distribution of the opioid receptor-like (ORL1) receptor
@en
Tissue distribution of the opioid receptor-like (ORL1) receptor
@nl
type
label
Tissue distribution of the opioid receptor-like (ORL1) receptor
@ast
Tissue distribution of the opioid receptor-like (ORL1) receptor
@en
Tissue distribution of the opioid receptor-like (ORL1) receptor
@nl
prefLabel
Tissue distribution of the opioid receptor-like (ORL1) receptor
@ast
Tissue distribution of the opioid receptor-like (ORL1) receptor
@en
Tissue distribution of the opioid receptor-like (ORL1) receptor
@nl
P1433
P1476
Tissue distribution of the opioid receptor-like (ORL1) receptor
@en
P2093
L Mouledous
P304
P356
10.1016/S0196-9781(00)00227-8
P407
P577
2000-07-01T00:00:00Z